Skip to main content
HR 661 119th Congress House Health Advanced technology and technological innovations Advisory bodies Data collection, sharing, protection Diplomacy, foreign officials, Americans abroad Employment and training programs Health promotion and preventive care Health technology, devices, supplies Intellectual property Israel Manufacturing Medical research Prescription drugs Public-private cooperation Supply chain

MIRACLE Medical Technology Act of 2025

Introduced: January 23, 2025 Introduced by: Buchanan, Vern Republican · Florida See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 23, 2025
Referred to the House Committee on Energy and Commerce.
Jan 23, 2025
Introduced in House
 Plain-English summary Congressional Research Service

Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025

This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.

What's happening now January 23, 2025

Referred to the House Committee on Energy and Commerce.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 2 Republican 1